(R)-2-[(R)-2-(BENZYLOXY)-1-(TERT.-BUTOXYCARBONYLAMINO)-2-OXO-ETHYL]-5-PHENYLPENTANOIC-ACID
Compound with spectra: 1 NMR
![(R)-2-[(R)-2-(BENZYLOXY)-1-(TERT.-BUTOXYCARBONYLAMINO)-2-OXO-ETHYL]-5-PHENYLPENTANOIC-ACID](/api/compound/HdYO55Yb6EI.png?ph=true&h=300&w=458 "(R)-2-[(R)-2-(BENZYLOXY)-1-(TERT.-BUTOXYCARBONYLAMINO)-2-OXO-ETHYL]-5-PHENYLPENTANOIC-ACID")
| SpectraBase Compound ID | HdYO55Yb6EI |
|---|---|
| InChI | InChI=1S/C25H31NO6/c1-25(2,3)32-24(30)26-21(23(29)31-17-19-13-8-5-9-14-19)20(22(27)28)16-10-15-18-11-6-4-7-12-18/h4-9,11-14,20-21H,10,15-17H2,1-3H3,(H,26,30)(H,27,28)/t20-,21-/m1/s1 |
| InChIKey | AMNSNOYNVGCDMG-NHCUHLMSSA-N |
| Mol Weight | 441.52 g/mol |
| Molecular Formula | C25H31NO6 |
| Exact Mass | 441.215138 g/mol |
| Enantiomer InChIKey | AMNSNOYNVGCDMG-SFTDATJTSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
Benzyl (2S,5R)-2-[(tert-butoxycarbonyl)amino]-5,6-isopropylidenedioxy-4-oxohexanoate
(2R)-2-(tert-butoxycarbonylamino)-4-[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]-4-keto-butyric acid benzyl ester
(2S)-2-(tert-butoxycarbonylamino)-4-(1-naphthyl)butyric acid benzyl ester
Methyl (1S,2R)-(-)-1-N-benzyloxycarbonylamino-2-carboxycyclopropanecarboxyloate
N-Benzyloxycarbonyl-A-benzyl-ester-D-L-A-amino-adipoyl-S-benzyl-L-cysteinyl-glycine benzyl ester
l-Leucine, N-[N-[(1,1-dimethylethoxy)carbonyl]-l-.alpha.-glutamyl]-, bis(phenylmethyl) ester
TERT.-BUTYLOXYCARBONYL-L-GLUTAMINYL-N(EPSILON)-BENZYLOXYCARBONYL-L-LYSINE-BENZYLESTER
BOC-PHE-LEU-O-CH2-PHE
BENZYL-(2S)-2-BENZYLOXYCARBONYLAMINO-3-(1-METHYL-5-HYDROXYPYRAZOL-4-YL)-PROPIONATE
BETA-BENZYL-[(2R)-N-(TERT.-BUTOXYCARBONYL)-ALPHA-METHYLGLUTAMYL]-GAMMA-SARCOSYL-[ALPHA-METHYL-(2R)-ASPARTATE]-TRIESTER;ROTAMER-#2
| Title | Journal or Book | Year |
|---|---|---|
| A Straightforward Approach to MMP-2 and MMP-9 Inhibitors Based on Chelate Claisen Rearrangements | European Journal of Organic Chemistry | 2011 |